Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT
Lantern Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.06M | 6.38M | 7.51M | 8.1M | 12.98M | 18.36M | 21.94M | 25.57M | 28.42M | 32.48M | 37.2M | 39.26M | 43.36M | 46.65M | 51.52M | 54.67M | 61.35M | 81.37M |
Short-Term Investments | 9.84M | 13.34M | 16.5M | 19.95M | 20.29M | 20M | 19.36M | 19.35M | 19.53M | 19.06M | 17.99M | 18.57M | 18.79M | 18.56M | 19.2M | 19.16M | 18.23M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 541.18K | 541.18K | 1M | 1M | n/a | n/a |
Other Long-Term Assets | 36.74K | 36.74K | 36.74K | 36.74K | 32.02K | 25.87K | 25.87K | 25.87K | 25.87K | 32.97K | 17.89K | 17.89K | 17.89K | 17.89K | 17.89K | 17.89K | 17.89K | n/a |
Receivables | n/a | n/a | 97K | n/a | n/a | n/a | 860K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -305K | -339K | -228K | -181K | n/a | n/a | n/a |
Other Current Assets | 1.3M | 1.1M | 1.14M | 748K | 2.03M | 1.11M | 745.65K | 2.5M | 3.09M | 2.1M | 541.18K | 3.15M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 17.2M | 20.82M | 25.25M | 29.92M | 35.29M | 39.47M | 43.34M | 47.43M | 51.04M | 55.17M | 58.72M | 62.02M | 65.66M | 67.66M | 72.72M | 76.34M | 82.13M | 82.48M |
Property-Plant & Equipment | 182.76K | 236.22K | 287.43K | 335.57K | 263.34K | 237.49K | 280.42K | 319.66K | 358.2K | 308.79K | 95.69K | 126.73K | 157.75K | 180.29K | 216.19K | 251.67K | 283.1K | 20.16K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 219.5K | 272.96K | 324.16K | 372.3K | 295.35K | 263.36K | 306.29K | 345.53K | 384.07K | 341.75K | 113.58K | 144.62K | 716.82K | 739.36K | 1.23M | 1.27M | 300.99K | 20.16K |
Total Assets | 17.42M | 21.1M | 25.57M | 30.29M | 35.59M | 39.73M | 43.65M | 47.77M | 51.43M | 55.51M | 58.84M | 62.16M | 66.38M | 68.4M | 73.95M | 77.61M | 82.43M | 82.5M |
Account Payables | n/a | 4.12M | 4.14M | 3.4M | 4.44M | 1.61M | 942.21K | 2.09M | 2.85M | 1.19M | n/a | 985.97K | 2.02M | 690.65K | 681.11K | 722.64K | 1.09M | 664.53K |
Deferred Revenue | n/a | n/a | n/a | n/a | -4.44M | -3.78M | -1.74K | n/a | -2.85M | -2.67M | n/a | -3.05M | -5.17B | -2.92M | -2.33B | -1.64M | n/a | n/a |
Short-Term Debt | 131.51K | n/a | n/a | n/a | 164K | 178.02K | 172.97K | 168.01K | 163.15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.75M | n/a | n/a | n/a | 4.27M | 5.76M | 1.39M | -168.01K | -163.15K | 1.49M | 2.75M | 2.06M | 3.16M | 2.23M | 1.49M | 914K | n/a | n/a |
Total Current Liabilities | 4.88M | 4.29M | 4.33M | 3.6M | 4.6M | 3.95M | 2.68M | 2.25M | 3.02M | 2.79M | 2.8M | 3.14M | 5.3M | 3.07M | 2.33M | 1.79M | 2.69M | 664.53K |
Long-Term Debt | 13.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 108.5K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 13.52K | 33.42K | 52.84K | 93.95K | 54.69K | 15.56K | 61.49K | 106.52K | 150.71K | 140.63K | n/a | 92.02K | 5.3M | 13.3K | 52.89K | 92.02K | 130.71K | 108.5K |
Total Liabilities | 4.9M | 4.32M | 4.38M | 3.7M | 4.66M | 3.97M | 2.74M | 2.36M | 3.17M | 2.93M | 2.8M | 3.14M | 5.3M | 3.09M | 2.38M | 1.88M | 2.82M | 773.03K |
Total Debt | 145.04K | 194.93K | 243.66K | 291.24K | 218.7K | 193.58K | 234.47K | 274.53K | 313.86K | 260.22K | 52.89K | 92.02K | 130.71K | 168.49K | 204.95K | 240.98K | 276.6K | 108.5K |
Common Stock | 1.08K | 1.08K | 1.08K | 1.08K | 1.08K | 1.08K | 1.07K | 1.09K | 1.09K | 1.09K | 1.09K | 1.09K | 1.08K | 1.08K | 1.11K | 1.12K | 1.12K | 1.12K |
Retained Earnings | -84.89M | -80.56M | -76.03M | -70.15M | -65.64M | -60.69M | -55.24M | -51.06M | -47.9M | -43.15M | -39.28M | -35.9M | -33.64M | -29.14M | -25.02M | -21.48M | -17.43M | -15.11M |
Comprehensive Income | 48.04K | 131.73K | 153.99K | -25.26K | -6.58K | 1.86K | -107.46K | -138.79K | -261.84K | -299.68K | -371.39K | -435.04K | -348.48K | -311.47K | -92.69K | -102.69K | -47.56K | 0.00 |
Shareholders Equity | 12.52M | 16.78M | 21.19M | 26.6M | 30.93M | 35.77M | 40.91M | 45.41M | 48.26M | 52.58M | 56.04M | 59.03M | 61.08M | 65.32M | 71.57M | 75.73M | 79.61M | 81.73M |
Total Investments | n/a | 13.34M | 16.5M | 19.95M | 20.29M | 20M | 19.36M | 19.35M | 19.53M | 19.06M | 17.99M | 18.57M | 18.79M | 18.56M | 19.2M | 19.16M | 18.23M | n/a |